Genentech, Inc.

This study tested whether adding a personalized cancer vaccine (RO7198457) to the immunotherapy drug pembrolizumab works better than pembrolizumab alone for people with advanced melanoma that hasn't been treated before. The trial included 131 participants with stage III or IV mel…

This early-stage trial tested a new drug called cevostamab in 355 people with multiple myeloma that had returned or stopped responding to other treatments. The main goals were to check the drug's safety and find the right dose. Participants received the drug through an IV, and re…

This study looked at how healthy adults tolerate injections of immunoglobulin G (a type of antibody) given under the skin. Researchers tested different injection conditions to see which caused the least pain and side effects. The goal was to gather safety information, not to trea…

This study looked at how the body absorbs ZN-A-1041 when given as a tablet compared to a capsule. It involved 18 healthy adults who took the drug in different forms. The goal was to see which form works best and how food or stomach acid medicine might affect absorption. No partic…